PROGRAM

Palace of the Academies, Brussels

Sunday May 25

Monday May 26

Tuesday May 27

Wednesday May 28

Time

Topic

14:00

Registration

16:00

Welcome and opening remarks

16:10

Official address

16:40

Playing chicken with antibiotics: global trends in antimicrobial resistance in animals and humans
Thomas Van Boeckel – University of Zurich (Switzerland)

17:10

Phages as friends and enemies in foods
Keynote speaker: Sylvain Moineau – Université Laval, Québec (CAN)

18:00

Welcome cocktail

8:50

Welcome day 1: One-Health - One-World challenges - Jacques Mahillon – UCLouvain, NaCoMi

Antimicrobial Resistance (AMR) in human and animal medicine – Chairs: Denis Piérard & Etienne Thiry

9:00

How is the antimicrobial selection pressure evolving in Belgium healthcare ?
Boudewijn Catry – Sciensano, Brussels (BEL)

9:25

The impact of COVID-19 on the antibiotic resistance in Gram-negative bacteria within Brussels' Intensive Care Units
Marco Moretti – VUB, Brussels (BEL)

9:50

Streptococcus suis infections in pigs, viewed from a one-health perspective
Dominiek Maes – UGent (BEL)

10:15

AMCRA, tackling antibiotic resistance in animals with a One-Health perspective
Fabiana Dal Pozzo – AMCRA, Brussels (BEL)

10:40

Coffee break

AMR in feed and food – Chairs: Jacques Mahillon & Koenraad Van Hoorde

11:05

Studies in wax moths, mice and humans establish that “Acceptable Daily Doses” of ciprofloxacin induce dysbiosis and antimicrobial resistance
Chris Kenyon – UAntwerp (BEL)

11:30

Metagenomics for AMR detection in food and feed: lessons learned from One Health applications and challenges ahead
Bram Bloemen – Sciensano, Brussels (BEL)

11:55

AMR bacteria and gene flow in the food system: Risks and mitigation measures
Pier Sandro Cocconcelli – Univ. Cattolica del Sacro Cuore, Piacenza (ITA) EFSA

12:20

Lunch & Group picture

AMR in agriculture and the environment – Chairs: Monica Höfte & Natalie Leys

14:00

Antifungal resistance in plant pathogenic fungi in North West Europe
Monica Höfte – UGent (BEL)

14:25

Land use drives drug resistance in a human fungal pathogen
Eveline Snelders – Wageningen University (NLD)

14:50

AMR in the clinical environment
Surbhi Malhotra-Kumar – UAntwerp (BEL)

15:15

Antimicrobial resistant pathogens in space environment: challenges and possible solutions
Elisabeth Grohmann – Berlin University of Applied Sciences (DEU)

15:40

Coffee break

Current regulations, legislations and challenges – Chair: Marc Heyndrickx

16:05

Where are the new antimicrobials? A tale of hope and despair
Pieter-Jan Ceyssens – Sciensano, Brussels (BEL)

16:30

Bacteriophages - New tool for One Health Approach to Mitigate AMR - Regulatory Challenges
Ewelina Wójcik – PhageEU & Proteon Pharmaceuticals, Lodz (POL)

16:55

Harvesting sustainable development and health together: Agri-food and One Health against AMR
Francesca Latronico – FAO, Roma (ITA) (Online)

17:15

Round Table

8:50

Welcome day 2: New strategies, new tools, new solutions - Jacques Mahillon – UCLouvain – NaCoMi (BEL)

Guardians of health: strategies for preventing infectious diseases – Chairs: Paul Cos & Jacques Mahillon

9:00

Rapid diagnostics for UTIs and sepsis
Wouter Van der Wijngaart – Royal Institute of Technology Stockholm (SWE)

9:25

From hospital wastewater systems to multidrug-resistant organism outbreaks: Understanding and combating environmental sources
Ahalieyah Anantharajah - UCLouvain (BEL)

9:50

Decolonization strategies against multidrug resistant organisms in the Intensive Care Unit
Stijn Blot – UGent (BEL)

10:15

Novel vaccines for respiratory viral infections: Can they reduce both viral disease burden and antibiotic usage?
Peter Delputte – UAntwerp (BEL)

10:40

Coffee break

New AB and beyond – Chairs: Charles Van der Henst & Cécile Boland

11:05

Next-Generation Antibiotics: Addressing Tomorrow's Challenges
Françoise Van Bambeke – UCLouvain (BEL)

11:30

Antimicrobial Peptides in preventive medicine: bridging fundamental science and clinical application
Laurence Van Moll - Milan Wouters – UAntwerp (BEL)

11:55

Bacterial quorum sensing systems as targets for antivirulence therapy
Tom Defoirdt – UGent (BEL)

12:20

Lunch

Phage and phage-related antimicrobial molecules – Chairs: Abram Aertsen & Damien Thiry

14:00

Expanding phage therapy treatment to Hidradenitis Suppurativa
Rob Lavigne – KU Leuven (BEL)

14:25

Environment-dependent phage evolution destabilizes the bacteria-phage coexistence mediated by phase variation
Nicolas Wenner – UBasel (Switzerland)

14:50

Clinical aspects of phage therapy: a Belgian experience
Sarah Djebara – Queen Astrid Military Hospital, Brussels (BEL)

15:15

Harnessing bacteriophage-derived particles for precision genetic circuit delivery: Antimicrobials and gene editing tools
Jesus Fernandez – Eligo Bioscience, Paris (FRA)

15:40

Coffee break

Novel technologies and future legislations – Chair: Philippe Gabant & Djamel Drider

16:05

Implementing personalised phage therapy
Jean-Paul Pirnay – Queen Astrid Military Hospital, Brussels (BEL)

16:30

Engineering customized and microbiome-friendly protein-based antibiotics
Yves Briers – UGent (BEL)

16:55

Health emergency preparedness and response authority (HERA)
Inmaculada Navarro – European Commission - DG HERA, Brussels (BEL)

17:20

Round Table

André Gratia’s legacy – Chair: Etienne Thiry

8:40

André Gratia’s ULB years: from early microbiology to major breakthroughs
Anne Botteaux – ULB, Brussels (BEL)

8:50

Homage to André Gratia (1893-1950), the father of bacteriocins
Etienne Thiry – ULiège (BEL) and Jean-Pierre Gratia – Pasteur Institute of Brussels (BEL)

9:10

Bacteriocins over the years: from discovery to ecological roles and therapeutic perspectives
Sylvie Rebuffat – Muséum national d'Histoire naturelle, Paris (FRA)

Short break

Discoveries of new bacteriocins – Chair: Drider Djamel

9:40

Trans-kingdom conservation of structure and mechanism in defensin-like bacteriocins
Ivan Sugrue – University College Cork (IRL)

10:05

An ABC exporter-GntR regulator system as a bacteriocin sensor for the control of antimicrobial peptide multi-resistance in streptococci
Julien Damocsi – UCLouvain, Louvain-la-Neuve (BEL)

10:30

Bacteriocins as a new strategy to inhibit the opportunistic human pathogen Streptococcus pneumoniae
Johann Mignolet – University of Lausanne (CHE)

10:55

Coffee break

News from the bench – Chair: Borrero Del Pino Juan

11:20

Design, engineering and control of microbial communities
Chris P. Barnes – University College London (GBR)

11:45

Invited Flash Speakers

12:25

Lunch

A new age for bacteriocins I – Chair: Johann Mignolet

14:00

Exploring circular bacteriocins: new approaches for production and engineering
Borrero Del Pino Juan – Universidad Complutense de Madrid (ESP)

14:25

Bacteriocins: Effective Food Preservatives or a Work in Progress ?
Célia Costa Gomes da Silva – Universidade dos Açores (PRT)

14:50

The Bac-Bac network: bacteriocins and bacteriophages in food biotechnology
Beatriz Martínez – IPLA, Villaviciosa (ESP)

15:15

Targeting outer membrane assembly machineries for new antibiotics
Jean François Collet – UCLouvain, Brussels (BEL)

15:40

Coffee break

A new age for bacteriocins II – Chairs: Philippe Gabant & Drider Djamel

16:00

The human microbiome as a source of, and target for novel antimicrobial peptides
Andreas Peschel – Tübingen University (DEU)

16:25

The Man-PTS paradox: why do so many bacteriocins target the same receptor?
Tamara Aleksandrzak-Piekarczyk – IBB, Warsaw (POL)

16:50

From bench to market, the amazing journey of the bacteriocin pediocin PA-1 and its analogues
Eric Biron – Laval University, Québec (CAN)

17:15

Closing remarks
Jacques Mahillon – UCLouvain

PROGRAM

Full Conference Tickets

Student Registration

Regular rate

Late rate

Partners

Sponsors

AS2AMR

Legal

Contact

Registrations

Partnerships

PROGRAM

Functional & Statistical Cookies

Full Conference Tickets

Student Registration

Regular rate

Late rate

Partners

Sponsors

AS2AMR

Legal

Contact

Registrations

Partnerships